These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 8487051)
21. Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial. Browman GP; Levine MN; Goodyear MD; Russell R; Archibald SD; Jackson BS; Young JE; Basrur V; Johanson C J Clin Oncol; 1988 Jun; 6(6):963-8. PubMed ID: 3286831 [TBL] [Abstract][Full Text] [Related]
22. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial]. Vacha P; Marx M; Engel A; Richter E; Feyerabend T Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135 [TBL] [Abstract][Full Text] [Related]
23. [Quality of life for patients treated for head and neck carcinoma]. Maingon P; Créhange G; Bonnetain F; Ligey-Bartolomeu A; Chamois J; Bruchon Y; Romanet P; Truc G Cancer Radiother; 2010 Oct; 14(6-7):526-9. PubMed ID: 20724192 [TBL] [Abstract][Full Text] [Related]
24. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline? Tribius S; Reemts E; Prosch C; Raguse M; Petersen C; Kruell A; Singer S; Bergelt C Oral Oncol; 2012 Sep; 48(9):898-904. PubMed ID: 22502815 [TBL] [Abstract][Full Text] [Related]
25. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. Xiao C; Zhang Q; Nguyen-Tân PF; List M; Weber RS; Ang KK; Rosenthal D; Filion EJ; Kim H; Silverman C; Raben A; Galloway T; Fortin A; Gore E; Winquist E; Jones CU; Robinson W; Raben D; Le QT; Bruner D Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):667-677. PubMed ID: 27727063 [TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. Budach W; Hehr T; Budach V; Belka C; Dietz K BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551 [TBL] [Abstract][Full Text] [Related]
27. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465 [TBL] [Abstract][Full Text] [Related]
28. Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy. Urba S; Gatz J; Shen W; Hossain A; Winfree K; Koustenis A; Peterson P; Cohen EE Oral Oncol; 2012 Aug; 48(8):723-9. PubMed ID: 22414289 [TBL] [Abstract][Full Text] [Related]
29. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. Wendt TG; Grabenbauer GG; Rödel CM; Thiel HJ; Aydin H; Rohloff R; Wustrow TP; Iro H; Popella C; Schalhorn A J Clin Oncol; 1998 Apr; 16(4):1318-24. PubMed ID: 9552032 [TBL] [Abstract][Full Text] [Related]
30. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Corvò R Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300 [TBL] [Abstract][Full Text] [Related]
31. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer. Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364 [TBL] [Abstract][Full Text] [Related]
32. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888 [TBL] [Abstract][Full Text] [Related]
33. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053 [TBL] [Abstract][Full Text] [Related]
34. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Kelly C; Paleri V; Downs C; Shah R Otolaryngol Head Neck Surg; 2007 Jan; 136(1):108-11. PubMed ID: 17210344 [TBL] [Abstract][Full Text] [Related]
35. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449 [TBL] [Abstract][Full Text] [Related]
36. Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study. Adelstein DJ; Kalish LA; Adams GL; Wagner H; Oken MM; Remick SC; Mansour EG; Haselow RE J Clin Oncol; 1993 Nov; 11(11):2136-42. PubMed ID: 8229127 [TBL] [Abstract][Full Text] [Related]
37. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM; Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466 [TBL] [Abstract][Full Text] [Related]
38. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA; J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667 [TBL] [Abstract][Full Text] [Related]
39. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483 [TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Milano MT; Vokes EE; Kao J; Jackson W; List MA; Stenson KM; Witt ME; Dekker A; MacCracken E; Garofalo MC; Chmura SJ; Weichselbaum RR; Haraf DJ Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]